Monthly Archive: February 2015

Feb 10

Researchers have determined that two mutations on a single gene can interact in a way that lowers the carrier’s risk for a heart attack.

Researchers have determined that two mutations on a single gene can interact in a way that lowers the carrier’s risk for a heart attack. The variants are found in a gene called DBH, which regulates an enzyme involved in the conversion of dopamine to norepinephrine. The research is published in a recent issue of the …

Continue reading »

Feb 09

Waiting until a patient’s systolic blood pressure exceeds 150 mm Hg before intensifying antihypertensive medication

Waiting until a patient’s systolic blood pressure exceeds 150 mm Hg before intensifying antihypertensive medication is associated with an increased risk of acute cardiovascular events and death, according to the results of a large analysis published in the BMJ.

Feb 06

Baseline and serial measures of high-sensitivity cardiac troponin T (hs-TnT)

Baseline and serial measures of high-sensitivity cardiac troponin T (hs-TnT) predict incident atrial fibrillation independently of traditional risk factors, suggests a new analysis from the Cardiovascular Health Study (CHS), published online in Heart Rhythm.

Feb 05

There seem to be no significant differences in pregnancy loss, need for high-level neonatal care

There seem to be no significant differences in pregnancy loss, need for high-level neonatal care, or overall maternal complications in women with mild-to-moderate hypertension at 14 to 33 weeks gestation randomized to tight vs. “less-tight” BP control, suggested an international trial. However, women assigned to tight BP control were significantly less likely to develop severe …

Continue reading »

Feb 03

Use of a high-sensitivity troponin (hs-Tn) assay and sex-specific diagnostic thresholds doubles the number of MI diagnoses in women presenting with ACS

Use of a high-sensitivity troponin (hs-Tn) assay and sex-specific diagnostic thresholds doubles the number of MI diagnoses in women presenting with ACS, suggests a prospective study that also suggested women are less likely to receive evidence-based treatment than men despite the same diagnosis. The report is published online in the BMJ.

Feb 02

Medtronic plc has revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR)

Medtronic plc has revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers advantages in survival and safety compared to surgical aortic valve replacement (SAVR) in high risk aortic stenosis patients who have previously undergone coronary artery bypass grafting (CABG) surgery. The findings were presented at the …

Continue reading »

Feb 02

Medtronic plc has revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR)

Medtronic plc has revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers advantages in survival and safety compared to surgical aortic valve replacement (SAVR) in high risk aortic stenosis patients who have previously undergone coronary artery bypass grafting (CABG) surgery. The findings were presented at the …

Continue reading »